Corewell Health is the new name for Beaumont.

More people than ever are surviving cancer; cancer survivors have unique health needs and concerns as result of their cancer and treatment. Radiation treatment for prostate, cervical, bladder, and colorectal cancers can also result in radiation exposure to the bladder. Some patients will experience progressive bladder problems 2-20 years after their radiation treatment.

Symptoms can include blood in their urine, increased voiding, having to use the bathroom multiple times per night, and chronic pain. In severe cases, the loss of blood through the bladder may be so significant that it requires hospitalization, blood transfusions, or even removal of the bladder. There are no curative therapies for Radiation or Hemorrhagic cystitis and no FDA approved drugs for this orphan disease.


Research Goals

 
  1. Understand why some patients develop Radiation Cystitis and how it occurs.
  2.  
  3. Develop new biomarker tests to determine if a cancer survivor is at risk of developing Radiation Cystitis.
  4.  
  5. Develop treatments and prevention methods for patients with Radiation Cystitis.
 Radiation Cystitis chemo

Collaborating with researches from around the world

  • Beaumont Health
    Royal Oak, MI, USA
  •  
  • University of Wisconsin
    Madison, WI, USA
  •  
  • Michigan State University
    Lansing, MI, USA
  •  
  • Universidad de Chile
    Santiago, Chile
  •  
  • Jagiellonian University
    Kraków, Poland